A151804 Biorepository (Cancers Treated with Immunotherapy) - Clinical Trial

What is the Purpose of this Study?

We are doing this study to help create a national biobank of samples and data about patients who experience side effects when they take immunotherapy drugs for their cancer. We want to find out why some people experience side effects and why others do not. We also want to learn more about how to diagnose and treat these side effects more effectively.

What is the Condition Being Studied?

Cancers Treated with Immunotherapy

Who Can Participate in the Study?

Adults ages 18+ who:

Are diagnosed with cancer and have not previously been treated with CTLA-4, PD-1, or PD-L1 inhibitors
Received a regimen containing one or more immuno-oncology therapeutics
Experienced one or more serious AEs during treatment
Have not previously been registered to this study

For more information, contact the study team at nick.jeffries@duke.edu.

Age Group

Adults

What is Involved?

You can choose to join this study if you are receiving immunotherapy as part of your cancer treatment. You may enroll before or after experiencing one or more side effects.